Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
- COMPASS investigators
Research output: Contribution to journal › Article › peer-review
385
Link opens in a new tab
Scopus
citations